Jane Street
BIND

Jane Street’s BIND THERAPEUTICS INC BIND Stock Holding History

Jane Street’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-11,078
Closed -$146K – 3558
2014
Q2 		$146K Buy
+11,078
New +$108K ﹤0.01% 2290

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jane Street's BIND Position: Q3 2014 in Review

Jane Street sold out of BIND THERAPEUTICS INC (BIND) in Q3 2014, closing a stake of 11,078 shares — an estimated $146K sold.

Jane Street first reported a position in BIND in Q2 2014 and held it in 1 quarter. The position peaked at $146K in Q2 2014. 40 funds tracked by Wall St. Rank hold BIND as of Q3 2014.

  • Jane Street reported no remaining BIND THERAPEUTICS INC position as of Q3 2014 after selling out during the quarter.
  • Jane Street sold 11,078 BIND THERAPEUTICS INC shares in Q3 2014, an estimated $146K.
  • Jane Street first reported a position in BIND THERAPEUTICS INC in Q2 2014 and held it in 1 quarter.
  • Jane Street's BIND THERAPEUTICS INC position peaked at $146K in Q2 2014.
  • 40 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2014.

Based on Jane Street's 13F filing for Q3 2014, filed 14 Nov 2014.